178 related articles for article (PubMed ID: 29522284)
21. Investigation on the mechanism of the combination of eremias multiocellata and cisplatin in reducing chemoresistance of gastric cancer based on
Cheng FE; Li Z; Bai X; Jing Y; Zhang J; Shi X; Li T; Li W
Aging (Albany NY); 2024 Feb; 16(4):3386-3403. PubMed ID: 38345573
[TBL] [Abstract][Full Text] [Related]
22. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
[TBL] [Abstract][Full Text] [Related]
23. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
24. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
25. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
26. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.
Cao W; Yang W; Fan R; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2014 Feb; 35(2):1287-95. PubMed ID: 24068565
[TBL] [Abstract][Full Text] [Related]
27. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
28. hsa_circ_0000520 influences herceptin resistance in gastric cancer cells through PI3K-Akt signaling pathway.
Lv X; Li P; Wang J; Gao H; Hei Y; Zhang J; Li S
J Clin Lab Anal; 2020 Oct; 34(10):e23449. PubMed ID: 32701211
[TBL] [Abstract][Full Text] [Related]
29. [Ethoxysanguinarine directly targets CIP2A to inhibit proliferation and induce autophagy of SGC7901/DDP cells].
Wan F; Tan M; Xiang YC; Liu XW; Peng P; Liu Y
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(21):5890-5899. PubMed ID: 36472008
[TBL] [Abstract][Full Text] [Related]
30. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
Wang Z; Liu C
PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
[TBL] [Abstract][Full Text] [Related]
31. Salidroside induces apoptosis and protective autophagy in human gastric cancer AGS cells through the PI3K/Akt/mTOR pathway.
Rong L; Li Z; Leng X; Li H; Ma Y; Chen Y; Song F
Biomed Pharmacother; 2020 Feb; 122():109726. PubMed ID: 31918283
[TBL] [Abstract][Full Text] [Related]
32. Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway.
Ao R; Guan L; Wang Y; Wang JN
J Cell Biochem; 2018 Jun; 119(6):4420-4434. PubMed ID: 29143985
[TBL] [Abstract][Full Text] [Related]
33. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
34. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
35. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways.
Wei J; Wang R; Lu Y; He S; Ding Y
Eur J Pharmacol; 2022 Feb; 916():174631. PubMed ID: 34774850
[TBL] [Abstract][Full Text] [Related]
36. Effect of Ag-1031 on apoptosis in gastric cancer AGS cells and its effects on the PI3K/AKT/mTOR signaling pathway.
Dai J; Liu D; Chen L; Sun L
Biotechnol Lett; 2020 Nov; 42(11):2447-2452. PubMed ID: 32651704
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
38. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR.
Ren J; Hu Z; Niu G; Xia J; Wang X; Hong R; Gu J; Wang D; Ke C
FASEB J; 2023 Mar; 37(3):e22790. PubMed ID: 36786694
[TBL] [Abstract][Full Text] [Related]
39. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
[TBL] [Abstract][Full Text] [Related]
40. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]